Outlook Therapeutics (OTLK) Q4 2024 Earnings

Dec 27Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.55
-1.05
-0.54
-0.04

Details

Expected EPS
-0.803333
Actual EPS
-0.88
Surprise EPS
-0.08
Surprise Percent
-9.54%

Description

⁨Outlook Therapeutics⁩ (⁦OTLK⁩) has reported earnings of ⁦-0.88⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts